Enhanced plasma soluble CD40 ligand levels in essential hypertensive patients with blunted nocturnal blood pressure decrease.

[1]  G. Lip,et al.  Abnormal soluble CD40 ligand and C-reactive protein concentrations in hypertension: relationship to indices of angiogenesis , 2006, Journal of hypertension.

[2]  G. Desideri,et al.  Endothelial activation. Sliding door to atherosclerosis. , 2005, Current pharmaceutical design.

[3]  G. Ma,et al.  Increased levels of CD40-CD40 ligand system in patients with essential hypertension. , 2005, Clinica chimica acta; international journal of clinical chemistry.

[4]  T. Ozgurtas,et al.  Soluble CD40 Ligand Levels in Patients with Hypertension , 2005, Clinical and experimental hypertension.

[5]  J. Dimsdale,et al.  Relation of nocturnal blood pressure dipping to cellular adhesion, inflammation and hemostasis , 2004, Journal of hypertension.

[6]  C. Patrono,et al.  Determinants of Platelet Activation in Human Essential Hypertension , 2004, Hypertension.

[7]  P. Libby,et al.  Soluble CD40L: Risk Prediction After Acute Coronary Syndromes , 2003, Circulation.

[8]  G. Lip,et al.  Pharmacological Modulation of Platelet Function in Hypertension , 2003, Hypertension.

[9]  D. Bereczki,et al.  Should soluble CD40 ligand be measured from serum or plasma samples? , 2003, Arteriosclerosis, thrombosis, and vascular biology.

[10]  G. Desideri,et al.  Effects of obesity and weight loss on soluble CD40L levels. , 2003, JAMA.

[11]  E. Terán,et al.  Physiological changes in platelet aggregation and nitric oxide levels during menstrual cycle in healthy women. , 2002, Nitric oxide : biology and chemistry.

[12]  Patrick André,et al.  Platelet-derived CD40L: the switch-hitting player of cardiovascular disease. , 2002, Circulation.

[13]  G. Davı̀,et al.  , Hypercholesterolemia : Effects of Statin Therapy Association Between Enhanced Soluble CD 40 L and Prothrombotic State in , 2002 .

[14]  P. Libby,et al.  Soluble CD40L and Cardiovascular Risk in Women , 2001, Circulation.

[15]  F. Magrini,et al.  Target organ damage and non-dipping pattern defined by two sessions of ambulatory blood pressure monitoring in recently diagnosed essential hypertensive patients , 2001, Journal of hypertension.

[16]  I. Kallikazaros,et al.  Microalbuminuria is associated with abnormal thoracic aortic mechanics in essential hypertension. , 2000, The American journal of cardiology.

[17]  K. Forfang,et al.  Enhanced levels of soluble and membrane-bound CD40 ligand in patients with unstable angina. Possible reflection of T lymphocyte and platelet involvement in the pathogenesis of acute coronary syndromes. , 1999, Circulation.

[18]  G. Parati,et al.  Reproducibility and clinical value of nocturnal hypotension: prospective evidence from the SAMPLE study , 1998, Journal of hypertension.

[19]  Reinhold Förster,et al.  CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells , 1998, Nature.

[20]  F. Cuccurullo,et al.  Arterial disease in dipper and nondipper hypertensive patients. , 1997, American journal of hypertension.

[21]  P. Libby,et al.  Functional CD40 ligand is expressed on human vascular endothelial cells, smooth muscle cells, and macrophages: implications for CD40-CD40 ligand signaling in atherosclerosis. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[22]  R. Kroczek,et al.  A soluble form of TRAP (CD40 ligand) is rapidly released after T cell activation , 1995, European journal of immunology.

[23]  G. Reboldi,et al.  Ambulatory blood pressure. An independent predictor of prognosis in essential hypertension. , 1994, Hypertension.

[24]  G. Schillaci,et al.  Blunted nocturnal fall in blood pressure in hypertensive women with future cardiovascular morbid events. , 1993, Circulation.

[25]  K. Shimada,et al.  Diurnal blood pressure variations and silent cerebrovascular damage in elderly patients with hypertension. , 1992, Journal of hypertension.

[26]  P Pignoli,et al.  Intimal plus medial thickness of the arterial wall: a direct measurement with ultrasound imaging. , 1986, Circulation.

[27]  G. Lip,et al.  High pulse pressure and nondipping circadian blood pressure in patients with coronary artery disease: Relationship to thrombogenesis and endothelial damage/dysfunction. , 2005, American journal of hypertension.

[28]  P. Libby,et al.  The CD40/CD154 receptor/ligand dyadRID="†"ID="†" Review , 2001, Cellular and Molecular Life Sciences CMLS.